| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |